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Abstract. The ability to stop all cellular  activity for a prolonged period of time, yet still be 
able to deliver functional recovery on demand, is the practical output of the science of 
cryobiology. This cessation of biological time allows cells to be preserved for months or years 
in medicine and biotechnology. This review discusses the historical development of 
cryobiology, the basic scientific principles underpinning cryopreservation, and how the 
technologies are currently used. 
1.  Introduction  
The impact of low temperatures on cells and tissues has held the fascination of natural scientists over 
many centuries. For example, Boyle, in his 17th century treatise recorded many observations on the 
mechano-physical effects of ice formation and freezing in natural systems [1]. In the same era 
Spallanzi [2] commented on the effects of cold to stop biological activity (motility) in spermatozoa of 
several species, using newly available microscopes and a century later Mantegazza [3] observed sperm 
cooled  and frozen below -10oC. He made the visionary comment that freezing temperatures might be 
used in some future time to set up sperm banks to facilitate animal breeding programmes in different 
countries.   Microscopy techniques allowed plant scientists to gain further insight into freezing and 
biology. For example in the 1890s  Molisch [4] developed a unique microscope system to observe the 
freezing process in plant tissues which immediately highlighted one of the central problems with ice 
formation: once ice starts to form, pure water was captured by the growing ice front and the cells 
became extremely dehydrated because the solutes in the original solution were concentrated in the 
remaining unfrozen liquid which progressively reduced in volume as lower and lower temperatures 
were reached. Immediately on thawing, multiple and extreme changes to cell structure were evident. 
Maximov [5] demonstrated that in order to tolerate seasonal ice formation in nature, plants cells often 
required a ‘hardening’ step ahead of freezing which was associated with production of high 
concentrations of sugars and other solutes in the tissues. Later understanding (see below) would 
elucidate that this accumulation of sugars can counteract the damaging ‘freeze dehydration’ associated 
with ice formation.  It was also an early indication that such similar solutes acted against osmotic 
injury as ‘osmolytes’ to protect either freezing injury or drought conditions in some plant species.  If 
they could be provided in other cases where cells were to be preserved by freezing, these ‘osmolytes’ 
might be used as natural ‘antifreezes’ or ‘cryoprotectants’ – literally solutes which would enhance 
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biological survival in the presence of ice.  In the early 20th century, this combined background 
knowledge base led to interest in applications of cryoprotectants (CPA) to provide successful 
cryogenic storage of cells, culminating in the seminal work of Polge, Smith & Parkes (1949). For the 
first time repeatable recovery of living cells from temperatures down to -79oC was demonstrated. This 
will be further discussed below.  
2.  The role of fundamental cryobiology to cell and tissue cryopreservation  
2.1 Historical Aspects  
The term ‘cryobiology’ first appeared in the 1960s, with establishment of the International Society for 
Cryobiology in 1963. The term cryopreservation is now widely used to signify storage of living cells 
at deep cryogenic temperatures (in the region of -170oC to -196oC). Our understanding of the 
biophysical processes involved has developed in the intervening time but is still as yet incomplete.  It 
has also become clear that attainment of the cryogenic state sufficiently stable to permit recovery of 
viable cells is possible by applying different approaches which achieve the same end point. These can 
be broadly described as controlled rate slow cooling (CRSC) or fast cooling rate vitrification (VT) and 
these will be discussed below. The term cryopreservation encompasses both.  Polge and colleagues [6] 
in fact applied CRSC to preserve fowl sperm using glycerol and sugars as CPA – although they 
understood that this was something different to ‘freezing’, because they actually used the term 
‘vitrification’ in the title of their work. It was only after another 20 years of research that it was 
understood that their approach was not VT as we know and apply it today.            
 
2.2 The importance of the water-ice phase transition in cryobiology 
Whilst low temperatures can disturb cell functions at many different levels, the injuries can take many 
hours or even days to become irreversible (for example red blood cells can be routinely stored for >20 
days in the chilled liquid state around +4oC); however the formation of ice even after cooling to only 
high sub-zero temperatures causes almost immediate cell disruption [7].  Early evidence suggested that 
no mechanical damage was produced by ice formation under these conditions, whereas the reduction 
of free water in the system following ice nucleation (ice forms only from water and excludes any 
dissolved solutes into the residual aqueous volume) leads to a significant hypertonic stress on the cells 
[7, 8] which was the key injury.  More detailed discussions on these topics can be found in later 
reviews [9, 10].  
    Once ice nucleation commences water molecules join ice crystals as spatially-defined arrays 
yielding the commonly observed hexagonal ice. In any CRSC protocol, ice preferentially nucleates in 
the external medium because cell membranes, to some extent, act as a barrier to ice crystal growth.   
The phase transition also results in the easily-detectable release of energy as the latent heat of ice 
formation, and can be a useful indicator of the underlying important physical processes in 
cryopreservation (see discussion on ‘ice seeding’ below).  The proportion of ice continues to grow 
from within the residual aqueous solution as colder temperatures are reached with a parallel 
progressive increase in percentage of water removed as ice, such that by about -6oC, some 80% of 
original water content has been removed as ice, starting from the isotonic solutions in which 
mammalian cells exist [7].   
   This might be considered to be an irreversibly damaging consequence of growing ice formation 
as deeper cryogenic temperatures are reached; however, at some point the whole matrix (ice, the tiny 
fraction of residual water, solute content and entrapped cells) undergoes another transition (see below) 
to a ‘pseudo-glassy’ state.  This ‘locks’ the system into a format which can remain stable over many 
years. There are multiple biological  targets for this extreme dehydration, including destabilisation of 
cell membranes and a change in the intracellular milieu (including pH, protein damage and disruption 
of essential organelles such as mitochondria and cytoskeleton), all of which can result individually or 
in combination in cell death [9, 10].   
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It will be clear that optimal cryogenic dehydration depends on the kinetics of water movement 
across the cell membranes, i.e. it is rate dependent. The outcome can be dictated by the rate of cooling, 
and if this rate is too high, there may be a sufficient residual cytoplasmic water fraction capable of 
nucleating ice in intracellular spaces.  Nucleation of ice and progressive intracellular ice formation 
(IIF) have been found in many cases to almost invariably result in lethal cell injury.  Using 
mammalian embryos or oocytes as model systems in cryobiology, many of these events have been 
identified using direct observation of the freezing processes by cryomicroscopy [11–13]. In fact, due 
to their large size these cells have been used to reveal many of the mechanistic effects of 
cryopreservation.  Cryomicroscopy also provided evidence that that one mode of action of the added 
protective solutes (or cryoprotecant addtives – CPA) included inhibiting IIF  during cryogenic cooling 
[14].  
 
3.  Cryoprotectants – the essential compatible solutes which protect against freezing injury 
A variety of biocompatible osmolytes were identified which impact favourably on cryopreservation 
processes, provided they can be delivered safely ahead of the cooling process. These became known 
collectively as cryoprotectants (CPA). Polge’s early work focused on the use of glycerol as a CPA [6], 
and studies indicated that solutes with a high propensity to form hydrogen bonds with water, such as 
sugars, other polyols, or in some cases polymers, were, in turn, often useful as CPA [15, 16].  It was 
suggested that these are solutes which can favourably impact on the nature and volume fraction of ice 
crystal growth during cooling. Protection is assured on a kinetic basis until cooling has progressed to 
sufficiently low temperatures that total solidification of the aqueous matrix occurs (which ‘locks-in’ 
the stabilised biological components). Progression to lower cryogenic temperatures is then without 
significant biological impact. Cryogenic cell preservation is often performed on a pragmatic basis to 
temperatures below -170oC, which are provided by the vapour phase or liquid phase of liquid nitrogen 
(LN2), because this has become the widely-accessible, relatively inexpensive cryogen of choice. 
However, living cells can be recovered from even lower temperatures such as -269oC [17].  
Most cells of interest for cryopreservation are suspended in isotonic (and dilute) aqueous salt 
solutions with effectively a very high water content. The chemico-physical properties of ice formation 
in such systems dictate that there is a large increase in salt concentrations (by more than x10 fold) in 
the residual aqueous fraction even at relatively high subzero temperatures such as -5 C [18]. An early 
explanation of CPA action was formulated on the depression of freezing point which follows from the 
addition of significant concentrations of an additional (biocompatible) solute, which in turn is a 
function of the molar concentration of the added CPA. This became known as the colligative action of 
CPAs [19] and explains why such high concentrations of CPA (often > 1M) are needed in 
cryopreservation.    
Once there was a basic understanding of CPA action, other compatible solutes were sought.  
Lovelock and Bishop identified the agent dimethyl sulphoxide [DMSO] in the 1960s [8] as a potential 
CPA and subsequently this has become one of the most widely recognised CPAs. The term 
‘cryoprotectant’ itself not was formally recognised until a decade later [20]. In reality only a small 
number of other hydrophilic solutes acting as primary CPAs have been shown to be effective.  For 
example in some areas (such as embryo cryopreservation) another polyol, propylene glycol (1,2 
propane diol, PrOH) is now widely used in CRSC, whilst ethylene glycol has been used in some 
instances for tissue cryopreservation [21, 22].   
In order to protect intracellular compartments, CPAs must cross cell membranes.  Effective CPAs 
such as DMSO and PrOH cross cell membranes to provide intracellular protection. Other agents 
modifying the water-ice phase transition (e.g. sugars or polymers) provide some CPA effects but less 
effectively [23].  CPAs can thus be pragmatically described as either cell-permeating (primary) or 
non-permeating (secondary) agents [16, 17] (see Table 1).  Non-permeating CPAs modulate ice crystal 
growth in the extra-cellular environment, but they cannot normally provide primary cryoprotection 
[23, 24]. Sugars such as trehalose and sucrose are often included in CPA mixes but at lower 
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concentrations (between 0.1-0.3M). Polymers such as polyethylene glycol have been used at between 
2 -5% w/v [25], whilst hydroxyethyl starch was found to be a beneficial additive to supplement 
DMSO [26]. In many cases adding secondary CPAs permits a reduction in the concentration of 
primary CPAs such as DMSO [26, 27] which helps to minimise CPA toxicities. In VT protocols ficoll 
has been used as a polymer additive  [28]. Such secondary CPA possess non-ideal solution properties 
and thus restrict the mobility of free water to join the growing ice fronts on a kinetic basis during  
cooling.     
Any agents which modify cell water relationships can exert wide-ranging toxicities in certain 
situations, and this is also true for CPA [16, 20]. Also, application of CPAs at concentrations of 1M or 
greater will have direct osmotic impact on cells [29–31], both during addition and equally during 
removal post-cryopreservation[32, 33]. Thus, CPA exposure protocols prior to cryopreservation must 
be optimised.  Chemical CPA toxicities may be mitigated by using lower exposure temperatures, but 
this reduces rates of intracellular diffusion [34]. For these reasons, step-wise, time and temperature 
CPA-controlled protocols have to be developed to minimise these risks.  Currently such interactions 
can only be partially modelled [31], so prospective empirical studies are also often needed.     
Transmembrane CPA permeation is largely a simple physico-chemical process. When the kinetics 
are considered, the temperature is critical.  For example, at ambient temperature, CPA permeation into 
mammalian oocytes requires around 10 minutes to approach equilibrium [35]. This process is faster at 
higher temperatures (e.g. 37oC), but this also exacerbates any chemical toxicities associated with the 
CPA. 
  
 
Table 1. Commonly used cryoprotectants  identified by choice of application as  widespread***,  
moderate**  or infrequenly-used* (e.g. for specific cell types) [36]  
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4.  The importance of cooling and warming rates, and temperature stability during cryo-storage.   
For successful cryopreservation, rates of cooling play an important role because these dictate the 
sustainable optimal cryo-dehydration which can be achieved during the transit through the high 
subzero temperature range down to the region where true long term cryo- stability can be assured.  A 
number of studies have now demonstrated this stability to be   below -100oC [37, 38]. Cryobiology 
research has documented that a physico-chemical ‘glassy’ state exists at about -120oC with the 
aqueous mixtures commonly encountered in cryopreservation,  which has been termed the Tg (glass 
transition).  Both CRSC and VT depend on control of temperature change but each with different 
optimal rates to achieve Tg whilst avoiding injury.  
 
4.1 Kinetics of optimal temperature change during CRSC 
The term ‘slow cooling’ is relative but early work in embryo cryopreservation indicated that success 
could be achieved using rates of about -0.3oC min-1  [17, 39]. Mazur and his colleagues [39] developed 
a ‘2-factor hypothesis’ to describe two different injury scenarios when cooling proceeded at rates 
either side of optimum (see figure 1). In particular, cooling rates must allow optimal cryo-dehydration 
to an extreme degree where there is no possibility for intracellular free water to form intracellular ice 
crystals (IIF), an event which is almost invariably lethal  [40].  During CRSC, the essential 
dehydrative force is ice formation itself, removing intracellular free water on a kinetic basis by 
osmosis [13]. Sub-optimal rapid cooling has been correlated with IIF, whilst suboptimal slow cooling 
was believed to result from over-long exposures to extreme cell dehydration before reaching Tg, with 
membrane bilayer disruption as one possible target [41].  Further details can be found elsewhere [42, 
43] and go some way to explain why cells cannot be successfully preserved long-term unless deep 
cryogenic temperatures are reached.  However, once this pathway has been successfully  negotiated, 
cell functionality  can be maintained for many years without change [44]. Needs for reliable control of 
cooling for CRSC have driven the development of  automated cryo-coolers using liquid nitrogen (LN2) 
vapour as the cryogen [45, 46] or Stirling engine cooling [26].  The temperature range for Tg for 
commonly-used CPA (around -120 C) also explains why long storage in liquid or vapour phase N2 (i.e. 
below -150oC) has been so successful [37, 38] because this is well below this critical Tg and provides a 
degree of safety against small storage temperature fluctuations having a negative impact on outcomes.  
As discussed, the achievement of optimal cryo-dehydration depends on intracellular free water 
moving across the cell membrane in osmotic response to the extracellular ice fraction which increases 
during cooling. This can be facilitated by ensuring extracellular ice forms as close to the equilibrium 
melting (or pragmatically, the equilibrium freezing) temperature of the mixture, in a process known as 
‘ice seeding’ in the sample, which can be achieved practically in a number of ways [43, 47].  
 
  
4.2 Vitrification – the alternative approach for cryopreservation 
Vitrification (VT) also depends on extreme cell cryo-dehydration, ultra-low temperatures and passage 
through Tg , but these are achieved in a different approach. Early work in cryobiology demonstrated 
that water molecules could be manipulated by various physical approaches at ultra-low temperatures 
to prevent ice nucleation and reach a ‘glassy state’, but only by cooling extremely rapidly [48, 49] 
under conditions which could not easily be transferred to routine cell cryopreservation. The seminal 
work from Rall and Fahy [50] later demonstrated that use of very high concentrations of CPA (e.g > 
50% w/w) could inhibit ice crystallisation using practically achievable cooling rates (in the range at or 
about -200oC min-1 and still achieve Tg ; using this approach mouse embryos were successfully 
cryopreserved by VT.  
However, such high CPA concentrations raised concerns about toxicity, and to mitigate this CPA 
mixtures were introduced whereby each component was added at concentrations below their toxic 
levels whilst maintaining the total combined CPA concentration [51]. VT is now applied routinely in 
areas such as human embryo cryopreservation [19, 50, 51] where low sample volumes (<10ul) can be 
cooled in special containers (such as pulled straws or cryoloops) with suitably fast cooling. Evidence 
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suggests that applied optimally, VT may yield more success in embryo cryopreservation than CRSC 
[52–54]. 
 
 
 
Figure 1. A simplified version of Mazur’s 2-factor hypothesis. A cell treated with CPA protection 
subjected to cooling at different rates. Maximum functional recovery (lower bell shaped curve) is 
achieved with an optimal cooling rate providing reversible cryo-dehydration occurring over the high 
subzero temperature range. If cooling is too slow, (left side of image) irreversible slow and excessive 
dehydration can take place which injures cell mebranes and organelles.  If cooling is too fast (right 
side of figure) , cells do not have time to optimally dehydrate, and residual intracellular water can 
form ice, which is again injurious and can compromise structure of organelles. For many nucleated 
mammalian cells, ‘optimal’ cooling equates to rates of around -0.5oC to -1oC per minute down to -
100oC and below. Reproduced from [47] with permission.   
 
4.3 The importance of robust storage temperatures for cell cryopreservation 
True long-term storage can only be assured at temperatures safely below the Tg for the commonly-
used CPA. Storage at higher subzero temperatures can result in slow but measurable ongoing attrition 
to recoverable cell function [55], but may yield useful safe periods if these are carefully defined; for 
example storage periods up to 10 years have been approved by FDA (Food & Drug Administration in 
USA) for cryopreserved red blood cells [56]. Storage in liquid or vapour phases of liquid N2 (<-170o 
C) provides such essential reliability. However, it must be remembered that accessing cryo-banks, or 
routine filling with cryogen, can cause temperature fluctuations which could prove harmful to cell 
viability. For example, experiments showed that significant temperature upshift (e.g. from -135oC to -
60oC) could occur within a few minutes of lifting storage racks out from a cryo-container [57]. 
Repeated temperature cycling through the Tg  range led to a decrease in cell functional recoveries [57] 
The choice of storage (in either liquid or vapour phase N2) for cell samples also needs 
consideration. There is a possibility to transfer infectious agents found in commercially produced LN2 
which is not a sterile product  [58]. For some VT applications, such as embryo cryopreservation, direct 
exposure to cryogen improves rapid cooling by direct plunging in ‘open devices. This has prompted 
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the proposal to use closed embryo containers  [59].  On the contrary, samples may be cooled and 
stored in vapour phase N2  but the relatively poor heat capacity of the vapour phase reduces achievable 
fast cooling rates and increases the risk of rapid and large temperature fluctuations when opening 
cryo-storage dewars. Temperature stability can be improved  by simple measures such as adding a 
copper rod [60] as a thermal ‘cold conductor’  up  from the cryogen reservoir  into the body of the 
storage dewar. In addition, ensuring temperature stability during transport of cryopreserved samples 
can be essential to avoid loss of function[61]. Best practice dictates adherence to written protocols and 
maintenance of proper temperature records in all parts of the pathways for storage and distribution.   
      
4.4 Importance of warming protocols for successful cryopreservation 
Successful recovery of embryos from cryopreservation requires the same focused attention to 
scientific principles as required during cooling.  Biophysical events are dictated by the increasing 
temperatures, and there are risks to embryo survival if warming is not optimised.   
As soon as cryopreserved cells warm above the Tg range (around -120oC), high solute damage can 
accumulate. Water molecules become mobile above -110oC, even in samples cooled under vitrification 
conditions [62], whilst slow frozen cells have a significant (extracellular) ice burden in the sample.  
During warming, existing ice crystals may undergo ice crystal growth and re-organisation (known as 
Ostwald ripening), which may impart further injury depending upon the kinetics of the process [63].  
Even with vitrification, small intracellular ice nucleation centres may have established during the 
cooling process, which did not grow to become injurious ice crystals once Tg was safely passed. 
However, once mobile water becomes available during warming, these nucleation centres may 
catalyse new or ongoing ice crystal growth , such that ‘freezing during thawing’ can be conceptualised 
[64].   
Whilst fast warming has traditionally been favoured for embryo rewarming protocols [65], the 
scientific principles for rewarming have yet to be fully understood.  Historically it has was argued that 
slow warming may be beneficial to allow time for osmotic re-equilibration processes to take place [17] 
when the highly shrunken cells start to encounter more liquid water as the ice matrix melts at high 
subzero temperatures. However, it has since been shown that slow warming could injure cells such as 
blastocyst embryos [66].  
Rapid warming rates have been shown to be very important for rewarming vitrified animal  and 
human embryos (60, 61). The risk of osmotic injury continues progressively even after the last ice 
crystal has melted, and during the essential CPA dilution phase, because there will initially be high 
CPA concentrations in the intracellular environs. Return of the cells  to normal culture conditions for 
assessment and selection can yield reverse osmosis and harmful cell  swelling unless CPA dilution 
steps are carefully controlled. These are the reasons that slow, step-wise CPA dilution protocols have 
been developed over many years [11, 68]. Also, inclusion of osmotic buffers such as sucrose during 
the dilution phase have been found to be helpful in mitigating injury [69].  
Currently fundamental knowledge on the cryobiology of warming and CPA dilution is incomplete, 
and protocols have been developed largely on an empirical basis.  As a technical note, terms such as 
‘fast’ or ‘slow’ warming are relative and should be defined and measured in any clinical protocol to 
ensure robust repeatability.  For example, different holding devices (e.g. vials, straws, loops) have 
different thermal characteristics which will impact on cell warming rates, irrespective of the 
temperatures of the warming baths used.    
 
5.  Summary 
The technologies and understanding of cell and tissue cryopreservation have developed rapidly over 
the past 40 years. There is widespread application of cryobiology in many areas including  
reproductive medicine, heamatopoietic stem cell treatments in cancer, targeted immune cell therapies 
such as CAR T – cells and  animal and plant gene banks [70–73]. Combining the evidence for the 
various events during cryopreservation, for example during CRSC, allows a schematic of the overall 
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process to be proposed (see figure 2)  However our understanding of cell survival during cryogenic 
preservation remains incomplete, with many outcomes being acceptable rather than optimal. Further 
research is needed to improve post-thaw recoveries and understand molecular impacts of 
cryopreservation on short and long-term outcomes for the recovered cells.   
 
 
 
 
Figure 2. A schematic for a CRSC protocol. A cell is shown moving through the process. In region I 
(top left) the cell is exposed to the CPA and cooled to a hypothermic temperature (+10oC) for a period 
of time to allow CPA to permeate into the cell.  In region II, cooling is then continued to the predicted 
temperature for the first ice nucleation to occur (often around -5oC). Steps may be taken to encourage 
ice nucleation by ‘ice seeding’. Ice nucleation can be detected both visually or by release of latent 
heat. Time is allowed (often about 10 minutes) to complete latent heat release before continuing slow 
cooling (in this case -1oC/min). Progressive cell cryo-dehydration occurs as the cell is cooled down to 
a deep low temperature (-80oC), close to the glass transition range of the mixture. After that, in region 
III, the cell can be safely cooled more rapidly down to the storage temperature (-196oC). In region IV, 
rewarming phase, the cell is warmed rapidly and osmotic balance is restored as free water is liberated 
from the ice fronts. In region V, the cell is carefully diluted out from the CPA solution and returned to 
normal environment.  Reproduced from [43] with permission.     
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